| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/11/2007 | US20070009551 Aids ancestral viruses and vaccines |
| 01/11/2007 | US20070009546 Isolated nucleic acid; screening for antibacterial compounds |
| 01/11/2007 | US20070009537 Antimicrobial activity of antibodies producing reactive oxygen species |
| 01/11/2007 | US20070009522 administering to an Rh-negative individual in need of an anti-Rh(D) monoclonal antibody, wherein monoclonal antibody exhibits a Fc gamma RTIII-type ADCC ( antibody-dependent cell-mediated cytotoxicity (ADCC) assays) level greater than 80% relative to a reference polyclonal anti-Rh(D) human antibody |
| 01/11/2007 | US20070009519 Immunoregulatory Antibodies and Uses Thereof |
| 01/11/2007 | US20070009513 Novel method of screening |
| 01/11/2007 | US20070009512 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains |
| 01/11/2007 | US20070009487 Minimal promoters and uses thereof |
| 01/11/2007 | DE19713543B4 Bakterielle Plasmide Bacterial plasmids |
| 01/11/2007 | DE102005031580A1 Substituierte Sulfolanylpyrazole und ihre Verwendung Substituted Sulfolanylpyrazole and their use |
| 01/11/2007 | CA2614017A1 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 01/11/2007 | CA2613962A1 Alkenyldiarylmethanes, fused analogs and syntheses thereof |
| 01/11/2007 | CA2613749A1 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 01/11/2007 | CA2613664A1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 01/11/2007 | CA2612241A1 Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
| 01/10/2007 | EP1741789A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 01/10/2007 | EP1741784A1 85kDa neisserial antigen |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741720A1 Modified DNA molecule, recombinant containing the same, and uses thereof |
| 01/10/2007 | EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 01/10/2007 | EP1741697A1 Crystal comprising (2r)-2-propyloctoic acid and amine |
| 01/10/2007 | EP1741443A2 Combination meningitidis B/C vaccines |
| 01/10/2007 | EP1741442A2 Neisseria meningitidis combination vaccines |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740603A2 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 01/10/2007 | EP1740599A1 Anthracycline derivatives |
| 01/10/2007 | EP1740595A1 Polycyclic macrolactones |
| 01/10/2007 | EP1740586A2 Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
| 01/10/2007 | EP1740582A1 Acyl dihydro pyrrole derivatives as hcv inhibitors |
| 01/10/2007 | EP1740566A1 Hki10311129, novel antibiotic, method for producing the same and the use thereof |
| 01/10/2007 | EP1740556A1 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 01/10/2007 | EP1740550A1 Sulphur-linked imidazole compounds for the treament of hiv |
| 01/10/2007 | EP1740206A2 Phep, an amino acid permease of staphylococcus aureus |
| 01/10/2007 | EP1740185A1 Benzodiazepines for treating or preventing rsv infection |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1416885B1 Devices for delivery of therapeutic agents with variable release profile |
| 01/10/2007 | EP1355916B1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/10/2007 | EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase |
| 01/10/2007 | EP1345945B1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 01/10/2007 | EP1280551B1 Vaccines against hiv infection |
| 01/10/2007 | EP1218011B1 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 01/10/2007 | EP1129213B1 Bacillus strain and assay methods |
| 01/10/2007 | EP1109803B1 Substituted imidazoles having cytokine inhibitory activity |
| 01/10/2007 | EP1087946B1 Aryl alkanoylpyridazines |
| 01/10/2007 | EP1078060B1 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 01/10/2007 | EP1017723B1 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 01/10/2007 | EP0918796B1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
| 01/10/2007 | EP0915705B1 Ionic polymers as anti-infective agents |
| 01/10/2007 | EP0914440B1 Nucleic acid vaccination for parvoviral infections |
| 01/10/2007 | EP0812357B1 A method for making heteromultimeric polypeptides |
| 01/10/2007 | EP0794793B1 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
| 01/10/2007 | CN1894399A Production of diphtheria toxin |
| 01/10/2007 | CN1894281A Treatment of viral infections |
| 01/10/2007 | CN1894259A Rifamycin analogs and uses thereof |
| 01/10/2007 | CN1894244A Aryl ether substituted imidazoquinolines |
| 01/10/2007 | CN1894239A Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 01/10/2007 | CN1894237A Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 01/10/2007 | CN1894236A Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1893966A Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 01/10/2007 | CN1893956A Doxycycline metal complex in a solid dosage form |
| 01/10/2007 | CN1891715A Inhibition of viral infection using monovalent antigen-binding proteins |
| 01/10/2007 | CN1891714A Ligand for herpes simplex virus entry mediator and methods of use |
| 01/10/2007 | CN1891713A Virulence genes and proteins, and their use |
| 01/10/2007 | CN1891710A L-nucleoside prodrug |
| 01/10/2007 | CN1891283A Chinese medicine composition, and its preparing method and quality control method |
| 01/10/2007 | CN1891264A Compound medicine for treating hepatitis B |
| 01/10/2007 | CN1891254A Food with Aids treating function |
| 01/10/2007 | CN1891252A Antivirus effective position of isatis root |
| 01/10/2007 | CN1891248A Medicinal composition for treating hepatopathy, and its preparing mehtod and use |
| 01/10/2007 | CN1891237A Active extract of a strictly anaerobic marine bacterium, and its preparing method and use |
| 01/10/2007 | CN1891235A Pheretima injection preparation and its preparing method |
| 01/10/2007 | CN1891231A Liusheng Chinese medicine preparation and its preparing method |
| 01/10/2007 | CN1891228A Baicalin dropping pill and its preparing method |
| 01/10/2007 | CN1891225A Adefovir dipivoxil self-emulsifiable preparation and its preparing method |
| 01/10/2007 | CN1891221A Combination therapy to treat hepatitis b virus |
| 01/10/2007 | CN1891220A 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 01/10/2007 | CN1891211A Method for preparing curcumin lyophilized liposome |
| 01/10/2007 | CN1294253C Bacterial strains, processed plant extract, composition containing thereof, preparation method and application in treatment and industry |
| 01/10/2007 | CN1294131C Pyrimidine compound |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293919C Application of short corynebacteria pharmaceutics or non-cell short corynebacteria pharmaceutics in preparing medicine of treating HIV infection or AIDS |
| 01/10/2007 | CN1293918C Preparation of clostridium welchil toxoid vaccine and antitoxin serum |
| 01/10/2007 | CN1293905C Application of single component Viola inconspicua in preparation of remedy for treating parotitis |
| 01/10/2007 | CN1293901C Chinese medicinal preparation for resisting herpes virus and preparing method thereof |
| 01/10/2007 | CN1293898C Method for preparing pharmaceutical composition for treating viral hepatitis |
| 01/10/2007 | CN1293884C Application of 6-methocy bideoxy bideoxy guanosine in preparation of medicine for resisting hepatitis B |
| 01/10/2007 | CN1293873C Andrographis herb preparation |
| 01/10/2007 | CN1293872C Oral cavity local administered pharmaceutical composition for treating pharyngitis and preparation method thereof |
| 01/09/2007 | US7160984 Process for preparing glycopeptide derivatives |
| 01/09/2007 | US7160983 1((-4-oxo- N2-(12-methyl-1-oxotetradecyl) L-ornithine) 4-(4-(4- hydroxyphenyl)-L-threonine)-5-L-serine-echinocandin B, and other derivatives |
| 01/09/2007 | US7160982 Peptide substrate identified by type BoNT/B botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 01/09/2007 | US7160914 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer |
| 01/09/2007 | US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160897 Therapeutic compounds |
| 01/09/2007 | US7160873 Texaphyrin coordination compounds and uses thereof |
| 01/09/2007 | US7160872 Methods to treat conditions mediated by chemokine receptors |
| 01/09/2007 | US7160854 Binaphthyl peptidomimetics for treating vancomycin resistant Staphylococcus aureas infections |
| 01/09/2007 | US7160685 Peptides having SEQ ID NO: 2 with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |